Advertisement
UK markets close in 5 hours 19 minutes
  • FTSE 100

    8,225.38
    -28.80 (-0.35%)
     
  • FTSE 250

    20,586.06
    -119.21 (-0.58%)
     
  • AIM

    804.84
    -3.52 (-0.44%)
     
  • GBP/EUR

    1.1758
    +0.0003 (+0.02%)
     
  • GBP/USD

    1.2756
    -0.0015 (-0.12%)
     
  • Bitcoin GBP

    53,216.62
    -390.46 (-0.73%)
     
  • CMC Crypto 200

    1,461.46
    -23.23 (-1.56%)
     
  • S&P 500

    5,306.04
    +1.32 (+0.02%)
     
  • DOW

    38,852.86
    -216.74 (-0.55%)
     
  • CRUDE OIL

    80.59
    +0.76 (+0.95%)
     
  • GOLD FUTURES

    2,345.10
    -11.40 (-0.48%)
     
  • NIKKEI 225

    38,556.87
    -298.50 (-0.77%)
     
  • HANG SENG

    18,477.01
    -344.15 (-1.83%)
     
  • DAX

    18,562.50
    -115.37 (-0.62%)
     
  • CAC 40

    7,987.38
    -70.42 (-0.87%)
     

Doximity (DOCS) To Report Earnings Tomorrow: Here Is What To Expect

DOCS Cover Image
Doximity (DOCS) To Report Earnings Tomorrow: Here Is What To Expect

Healthcare professional network Doximity (NYSE:DOCS) will be announcing earnings results tomorrow after market close. Here's what to look for.

Doximity beat analysts' revenue expectations by 6.1% last quarter, reporting revenues of $135.3 million, up 17.4% year on year. It was a weaker quarter for the company, with revenue guidance for the next quarter missing analysts' expectations.

Is Doximity a buy or sell going into earnings? Read our full analysis here, it's free.

This quarter, analysts are expecting Doximity's revenue to grow 4.9% year on year to $116.4 million, slowing from the 18.5% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $0.20 per share.

Doximity Total Revenue
Doximity Total Revenue

The majority of analysts covering the company have reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Doximity has a history of exceeding Wall Street's expectations, beating revenue estimates every single time over the past two years by 2.8% on average.

ADVERTISEMENT

Looking at Doximity's peers in the vertical software segment, some have already reported their Q1 results, giving us a hint as to what we can expect. Olo delivered year-on-year revenue growth of 27.3%, beating analysts' expectations by 3.5%, and Unity reported a revenue decline of 8%, topping estimates by 6.2%. Olo's stock price was unchanged after the results, while Unity was down 10.3%.

Read our full analysis of Olo's results here and Unity's results here.

There has been positive sentiment among investors in the vertical software segment, with share prices up 4.9% on average over the last month. Doximity is down 5.7% during the same time and is heading into earnings with an average analyst price target of $29.8 (compared to the current share price of $23.63).

When a company has more cash than it knows what to do with, buying back its own shares can make a lot of sense–as long as the price is right. Luckily, we’ve found one, a low-priced stock that is gushing free cash flow AND buying back shares. Click here to claim your Special Free Report on a fallen angel growth story that is already recovering from a setback.